Clinical Trials Directory

Trials / Completed

CompletedNCT06002308

Influence of Injury to the Kaplan Fibers in Adult and Pediatric Patients With ACL Injury

Influence of Injury to the Kaplan Fibers and Anterolateral Ligament on Anterolateral Rotatory Knee Laxity in Adult and Pediatric Patients With Anterior Cruciate Ligament Injury: A Retrospective Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
540 (actual)
Sponsor
Sichuan Province Orthopetic Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The goal of this \[type of study: observational study\] is to \[detect concomitant KF and ALL injury in knees with ACL injury using MRI in both adult and pediatric patients and compare the effect of KF injury and multiple risk factors (concomitant injury to the ALL, medial collateral ligament \[MCL\], or anterior, central, or posterior part of the medial or lateral meniscus) on anterolateral rotatory laxity as measured by the pivot-shift test in a clinical setting.\]. The main question \[s\] it aims to answer are: \[Does the main risk factor for a high-grade pivot shift after acute ACL injury differ between pediatric patients and adults?\] \[Does Concomitant KF injury significantly affect the pivot-shift phenomenon in pediatric patients with acute ACL injury?\] Researchers will compare \[71 pediatric patients and 469 adults\] to see if \[main risk factor for a high-grade pivot shift after acute ACL injury differs between pediatric patients and adults?\].

Conditions

Interventions

TypeNameDescription
OTHERAgeThe retrospective study included 540 patients with primary ACL tears (71 pediatric patients and 469 adults) whose MRI examination and pivot-shift test were conducted within 14 days after injury. To detect concomitant KF and ALL injury in knees with ACL injury using MRI in both adult and pediatric patients and compare the effect of KF injury and multiple risk factors on anterolateral rotatory laxity as measured by the pivot-shift test in a clinical setting.

Timeline

Start date
2023-06-20
Primary completion
2023-06-22
Completion
2023-06-22
First posted
2023-08-21
Last updated
2023-08-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06002308. Inclusion in this directory is not an endorsement.